Allarity Therapeutics Inc (ALLR)

Jun 17, 2025

Allarity Therapeutics Holds Annual Stockholders Meeting - TipRanks

Jun 17, 2025

Jun 13, 2025

Allarity Therapeutics Stock Nears Yearly Low: A Trader’s High-Risk Analysis - thekhabrilal

Jun 13, 2025

Jun 12, 2025

Allarity Therapeutics, Inc Announces Changes to Board of Directors - MarketScreener

Jun 12, 2025

Jun 11, 2025

Allarity Therapeutics appoints pharma veteran Høiland to board By Investing.com - Investing.com India

Jun 11, 2025

Jun 11, 2025

Allarity Therapeutics Appoints Jesper Høiland to Board - TipRanks

Jun 11, 2025

Jun 11, 2025

Allarity Therapeutics Announces Changes To Board Of Directors - MarketScreener

Jun 11, 2025

Jun 11, 2025

Allarity Therapeutics appoints pharma veteran Høiland to board - Investing.com

Jun 11, 2025

Jun 11, 2025

Allarity Therapeutics Announces Changes to Board of Directors - GlobeNewswire

Jun 11, 2025

Jun 11, 2025

Pharma Veteran Jesper Høiland Brings 30 Years Experience to Allarity Board Amid Clinical Momentum - Stock Titan

Jun 11, 2025

Jun 10, 2025

Allarity Therapeutics (NASDAQ:ALLR) Shares Up 4.2% – Here’s Why - Defense World

Jun 10, 2025

Jun 08, 2025

Wolf Haldenstein Adler Freeman & Herz LLP Announces that it is Investigating Allarity Therapeutics, Inc. for Potential Violations of Federal Securities Laws - ACCESS Newswire

Jun 08, 2025

Jun 06, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Allarity Therapeutics, Inc. (ALLR) Investors to Inquire about Securities Investigation - ACCESS Newswire

Jun 06, 2025

Jun 05, 2025

Allarity Therapeutics Partners with Indiana Biosciences - TipRanks

Jun 05, 2025

Jun 05, 2025

Allarity Therapeutics, Inc. (NASDAQ:ALLR) Short Interest Update - Defense World

Jun 05, 2025

Jun 04, 2025

Allarity Therapeutics partners with IBRI on cancer drug research By Investing.com - Investing.com South Africa

Jun 04, 2025

Jun 04, 2025

Allarity Teams With IBRI To Advance Dual-Action Cancer Drug Stenoparib - Nasdaq

Jun 04, 2025

Jun 04, 2025

Allarity Therapeutics partners with IBRI on cancer drug research - Investing.com Australia

Jun 04, 2025

Jun 04, 2025

Allarity Therapeutics Announces Research Collaboration with Indiana Biosciences Research Institute to Advance Understanding of Stenoparib's Mechanism of Action - Nasdaq

Jun 04, 2025

Jun 04, 2025

Allarity Therapeutics Announces Research Collaboration with - GlobeNewswire

Jun 04, 2025

Jun 04, 2025

Allarity Therapeutics Announces Research Collaboration with Indiana Biosciences Research Institute to Further Advance Understanding of Stenoparib’s Unique, Dual Therapeutic Mechanism of Action - Yahoo

Jun 04, 2025

Jun 03, 2025

Allarity Therapeutics Launches Phase 2 Trial for Stenoparib - TipRanks

Jun 03, 2025

Jun 02, 2025

Allarity Therapeutics Announces First Patient Enrolled in - GlobeNewswire

Jun 02, 2025

Jun 02, 2025

Allarity Therapeutics Announces First Patient Enrolled in New Phase 2 Clinical Trial Protocol of Stenoparib in Advanced Ovarian Cancer - The Manila Times

Jun 02, 2025

Jun 02, 2025

Allarity Therapeutics Enrolls First Patient in Phase 2 Trial of Stenoparib for Advanced Ovarian Cancer - Nasdaq

Jun 02, 2025

Jun 02, 2025

Revolutionary Ovarian Cancer Drug Begins Phase 2 Trial: Could Replace Traditional Chemotherapy - Stock Titan

Jun 02, 2025

May 25, 2025

ALLR ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Allarity Therapeutics, Inc. - ACCESS Newswire

May 25, 2025

May 24, 2025

Allarity Therapeutics (NASDAQ:ALLR) Stock Rating Upgraded by Wall Street Zen - Defense World

May 24, 2025

May 13, 2025

Allarity Therapeutics CEO to Present at Pharma Summit - TipRanks

May 13, 2025

May 12, 2025

Allarity Therapeutics Announces Participation in Pharma Partnering Summit US - GlobeNewswire

May 12, 2025

May 10, 2025

Metrics That Matter About Allarity Therapeutics Inc (NASDAQ: ALLR) - Stocksregister

May 10, 2025

May 09, 2025

Allarity Therapeutics Reports Positive Clinical Updates and Financial Highlights for Q1 2025 - Nasdaq

May 09, 2025

May 09, 2025

Allarity Therapeutics Provides First Quarter 2025 Update, - GlobeNewswire

May 09, 2025

May 09, 2025

Allarity Therapeutics Provides First Quarter 2025 Update, Highlighting Continued Stenoparib Benefit and Upcoming Trial Enrollment - Stock Titan

May 09, 2025

May 02, 2025

You might want to take a look at Allarity Therapeutics Inc (ALLR) now - Sete News

May 02, 2025

Apr 30, 2025

Was anything positive for Allarity Therapeutics Inc (ALLR) stock last session? - uspostnews.com

Apr 30, 2025

Apr 29, 2025

The Psychology of Allarity Therapeutics Inc Inc. (ALLR) Price Performance: Understanding Market Sentiment - investchronicle.com

Apr 29, 2025

Apr 29, 2025

Upward Trajectory: Allarity Therapeutics Inc (ALLR) Posts a Slidee, Closing at 1.07 - DWinneX

Apr 29, 2025

Apr 28, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 28, 2025

Apr 25, 2025

Allarity unveils new multiple myeloma treatment predictor - Investing.com

Apr 25, 2025

Apr 25, 2025

Allarity unveils new multiple myeloma treatment predictor By Investing.com - Investing.com South Africa

Apr 25, 2025

Apr 25, 2025

Healthy Upside Potential: Allarity Therapeutics Inc (ALLR) - Sete News

Apr 25, 2025

Apr 25, 2025

Allarity Therapeutics Presents Novel Drug Response - GlobeNewswire

Apr 25, 2025

Apr 25, 2025

Novel AI Predictor Identifies Multiple Myeloma Patients for Targeted Treatment | ALLR Stock News - Stock Titan

Apr 25, 2025

Apr 23, 2025

Ratios Revealed: Decoding Allarity Therapeutics Inc (ALLR)’s Financial Health - DWinneX

Apr 23, 2025